251 related articles for article (PubMed ID: 18615506)
1. Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004.
Zhou Y; Wang H; Fang W; Romaguer JE; Zhang Y; Delasalle KB; Kwak L; Yi Q; Du XL; Wang M
Cancer; 2008 Aug; 113(4):791-8. PubMed ID: 18615506
[TBL] [Abstract][Full Text] [Related]
2. Extranodal Head and Neck Mantle Cell Lymphoma: Characteristics, Treatment, and Survival.
Breen CT; Chao J; Mehra S; Kohli N
Ann Otol Rhinol Laryngol; 2022 Apr; 131(4):412-419. PubMed ID: 34137303
[TBL] [Abstract][Full Text] [Related]
3. An upward trend in the age-specific incidence patterns for mantle cell lymphoma in the USA.
Aschebrook-Kilfoy B; Caces DB; Ollberding NJ; Smith SM; Chiu BC
Leuk Lymphoma; 2013 Aug; 54(8):1677-83. PubMed ID: 23350889
[TBL] [Abstract][Full Text] [Related]
4. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
5. Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study.
Wang H; Chen Y; Li F; Delasalle K; Wang J; Alexanian R; Kwak L; Rustveld L; Du XL; Wang M
Cancer; 2012 Aug; 118(15):3793-800. PubMed ID: 22139816
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in mantle cell lymphoma in the United States.
Wang Y; Ma S
BMC Cancer; 2014 Oct; 14():764. PubMed ID: 25315847
[TBL] [Abstract][Full Text] [Related]
7. Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: A comparative study between Texas and National SEER areas.
Fu S; Wang M; Lairson DR; Li R; Zhao B; Du XL
Oncotarget; 2017 Dec; 8(68):112516-112529. PubMed ID: 29348844
[TBL] [Abstract][Full Text] [Related]
8. Mantle cell lymphoma epidemiology: a population-based study in France.
Leux C; Maynadié M; Troussard X; Cabrera Q; Herry A; Le Guyader-Peyrou S; Le Gouill S; Monnereau A
Ann Hematol; 2014 Aug; 93(8):1327-33. PubMed ID: 24763513
[TBL] [Abstract][Full Text] [Related]
9. Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability.
Odejide OO; Cronin AM; Earle CC; LaCasce AS; Abel GA
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26438575
[TBL] [Abstract][Full Text] [Related]
10. Increase in survival for patients with mantle cell lymphoma in the era of novel agents in 1995-2013: Findings from Texas and national SEER areas.
Fu S; Wang M; Li R; Lairson DR; Zhao B; Du XL
Cancer Epidemiol; 2019 Feb; 58():89-97. PubMed ID: 30528835
[TBL] [Abstract][Full Text] [Related]
11. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.
Hance KW; Anderson WF; Devesa SS; Young HA; Levine PH
J Natl Cancer Inst; 2005 Jul; 97(13):966-75. PubMed ID: 15998949
[TBL] [Abstract][Full Text] [Related]
12. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995.
Groves FD; Linet MS; Travis LB; Devesa SS
J Natl Cancer Inst; 2000 Aug; 92(15):1240-51. PubMed ID: 10922409
[TBL] [Abstract][Full Text] [Related]
13. Rising incidence of renal cell cancer in the United States.
Chow WH; Devesa SS; Warren JL; Fraumeni JF
JAMA; 1999 May; 281(17):1628-31. PubMed ID: 10235157
[TBL] [Abstract][Full Text] [Related]
14. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
15. Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries.
Augustin A; Le Gouill S; Gressin R; Bertaut A; Monnereau A; Woronoff AS; Trétarre B; Delafosse P; Troussard X; Moreau A; Hermine O; Maynadié M
J Cancer Res Clin Oncol; 2018 Apr; 144(4):629-635. PubMed ID: 29022078
[TBL] [Abstract][Full Text] [Related]
16. Results from the Belgian mantle cell lymphoma registry.
Vergote V; Janssens A; André M; Bonnet C; Van Hende V; Van Den Neste E; Van Eygen K; Maerevoet M; Pranger D; Schroyens W; Debussche S; Maertens V; Beel K; Lemmens J; Caron C; Delrieu V; Van Den Broeck I; Vanstraelen G; Jacquy C; Schauvlieghe L; De Samblanx H; Madoe V; Meers S; Boulet D; Verhoef G; Van Hoof A
Acta Clin Belg; 2017 Jun; 72(3):172-178. PubMed ID: 28222652
[TBL] [Abstract][Full Text] [Related]
17. The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.
O'Neill BP; Decker PA; Tieu C; Cerhan JR
Am J Hematol; 2013 Dec; 88(12):997-1000. PubMed ID: 23873804
[TBL] [Abstract][Full Text] [Related]
18. Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017.
Holm F; Mikkelsen LH; Kamper P; Rasmussen PK; Larsen TS; Sjö LD; Heegaard S
Br J Ophthalmol; 2021 Jul; 105(7):914-920. PubMed ID: 32732342
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease.
Medeiros LJ; Greiner TC
Cancer; 1995 Jan; 75(1 Suppl):357-69. PubMed ID: 8001007
[TBL] [Abstract][Full Text] [Related]
20. Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma.
Cohen JB; Han X; Jemal A; Ward EM; Flowers CR
Cancer; 2016 Aug; 122(15):2356-63. PubMed ID: 27153197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
